Italian Study Tracks Survival Divide in Twins With Parkinson’s

Ten-year mortality among Parkinson’s disease patients reached 31.5% in a cohort of 108 Italian twins, compared to just 5.6% in their unaffected co-twins, according to a longitudinal study published in Brain Sciences. Researchers tracking 54 twin pairs discordant for the neurodegenerative disorder found that shared genetic backgrounds and early environments could not fully account for the stark survival gap that opened over a decade.

Ten-Year Mortality Diverges Between Affected Twins and Unaffected Co-Twins

The study enrolled 54 Parkinson’s disease-discordant twin pairs, consisting of 26 monozygotic and 28 dizygotic pairs with an average age of 66 years at baseline. Over the ten-year follow-up, 17 participants with Parkinson’s died, representing 31.5% of the affected group. In contrast, only three unaffected co-twins died, accounting for 5.6% of that cohort. Within the monozygotic subgroup, where twins share 100% of their genetic material, all nine recorded deaths occurred in the members diagnosed with the disorder.

Reported causes of death among the affected twins included cardiovascular events, neurodegenerative disease complications, cancer, COVID-19, and other unspecified factors. Unaffected co-twins experienced three deaths, divided between cancer and unspecified causes. Cumulative survival curves showed a clear divergence over time, with the separation appearing more pronounced in the monozygotic subgroup, though small overall death counts left the exact magnitude uncertain.

Constipation and Clinical Progression Worsen Over Time in Affected Participants

Clinical tracking revealed that affected twins experienced constipation significantly more frequently than their unaffected co-twins at baseline, a disparity that widened further over the ten-year span among reassessed pairs. Regular bowel habits grew increasingly uncommon for those diagnosed with the condition, while unaffected co-twins showed no significant bowel function changes. Disease duration and prescribed levodopa doses increased for surviving patients across the decade.

Researchers evaluated baseline and follow-up data on lifestyle habits, noting that active smoking was initially more frequent among unaffected co-twins, though the difference lacked statistical significance. Smoking rates remained largely stable across both groups over the ten-year period. Lifetime exposure to organic solvents, pesticides, and herbicides appeared more frequent among affected twins initially, but that difference lost statistical significance after correction for multiple comparisons and remained vulnerable to recall bias.

Nutritional Status and Dietary Habits Show Limited Within-Pair Differences

Body weight and body mass index measurements showed no significant divergence between affected and unaffected twins at baseline or follow-up, regardless of whether the pair was monozygotic or dizygotic. Follow-up weight data relied on self-reporting, which researchers noted limited the precision of long-term nutritional comparisons. Most dietary habits remained uniform within pairs, assessed via food frequency questionnaires administered at the study’s start and end points.

Two specific dietary patterns showed variation. Affected twins reported lower fish intake at baseline and follow-up, though only the later difference maintained significance after internal dietary corrections. Fruit intake was lower at baseline for affected twins but higher at follow-up, with baseline differences reaching significance only in the monozygotic subgroup. Investigators cautioned that the shift from in-person questionnaires to telephone interviews at follow-up, alongside measuring consumption frequency rather than exact quantity, may have influenced reported dietary shifts.

Monozygotic Twin Conversion Challenges Simple Genetic Explanations

By the ten-year mark, two monozygotic twin pairs had lost their discordant status because the previously unaffected co-twin developed Parkinson’s disease. In one instance, the initially diagnosed twin had a 15-year disease history while the newly diagnosed co-twin showed symptom onset 14.5 years later. The second pair exhibited a 12-year gap between the respective diagnoses.

This conversion among genetically identical individuals indicates that disease manifestation can occur at vastly different ages despite shared DNA and intrauterine environments. Comorbidities such as hypertension showed no statistically significant differences within pairs at baseline or follow-up. The authors stated that while secondary findings emerged within individual categories, none retained significance after correction across all 78 statistical comparisons, leaving mechanisms that link disease progression to survival open to further investigation.

Study Enrolls 54 Twin Pairs to Track Mortality Differences

How many twin pairs were included in the ten-year study?

The research enrolled 54 twin pairs discordant for Parkinson’s disease, comprising 26 monozygotic pairs and 28 dizygotic pairs, totaling 108 participants with an average age of 66 years.

What was the mortality difference between affected and unaffected twins?

Over the ten-year follow-up, 17 twins with Parkinson’s died (31.5%), compared to three deaths among unaffected co-twins (5.6%). In the monozygotic subgroup, all nine recorded deaths occurred in the affected members.

Did dietary habits or weight change significantly between the twins?

Body weight and body mass index showed no significant differences within pairs at baseline or follow-up. While fish and fruit intake showed some variations over time, most dietary habits remained similar between affected individuals and their healthy co-twins.